Activation of factor VII during alimentary lipemia occurs in healthy adults and patients with congenital factor XII or factor XI deficiency, but not in patients with factor IX deficiency

Blood

Volumn 87, Issue 10, 1996, Pages 4187-4196

  Miller, George J ^a   Martin, Janet C ^b   Mitropoulos, Kostas A ^b   Esnouf, M Peter ^b   Cooper, Jacqueline A ^b   Morrissey, James H ^b   Howarth, David J ^b   Tuddenham, Edward G D ^b  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 9; CHOLESTEROL;

ADULT; ARTICLE; BLOOD CLOTTING FACTOR DEFICIENCY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY RISK; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MALE; POSTPRANDIAL STATE; PRIORITY JOURNAL; REGULATORY MECHANISM; RISK ASSESSMENT;

EID: 0029985985     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.10.4187.bloodjournal87104187     Document Type: Article

References (58)

1. Morrissey JH, Macik BG, Neuenschwander PF, Comp PC: Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood 81:734, 1993
2. Wildgoose P, Nemerson Y, Hansen LL, Nielsen FE, Glazer S, Hedner U: Measurement of basal levels of factor VIIa in hemophilia A and B patients. Blood 80:25, 1992
3. Seligsohn U, Kasper CK, Osterud B, Rapaport SI: Activated factor VII: Presence in factor IX concentrates and persistence in the circulation after infusion. Blood 53:828, 1979
4. Fair DS: Quantitation of factor VII in the plasma of normal and warfarin-treated individuals by radioimmunoassay. Blood 62:784, 1983
5. Hasselback R, Hjort PF: Effect of heparin on in vivo turnover of clotting factors. J Appl Physiol 15:945, 1960
6. Bajaj SP, Rapaport SI, Brown SF: Isolation and characterization of human factor VII. Activation of factor VII by factor Xa. J Biol Chem 256:253, 1981
7. Seligsohn U, Osterud B, Brown SF, Griffin JH, Rapaport SI: Activation of human factor VII in plasma and in purified systems. Roles of activated factor IX, kallikrein and activated factor XII. J Clin Invest 64:1056, 1979
8. Radcliffe R, Bagdasarian A, Colman R, Nemerson Y: Activation of bovine factor VII by Hageman factor fragments. Blood 50:611, 1977
9. Radcliffe R, Nemerson Y: Activation and control of factor VII by activated factor X and thrombin. J Biol Chem 250:388, 1975
10. Miller GJ, Stirling Y, Esnouf MP, Heinrich J, van de Loo J, Kienast J, Wu KK, Morrissey JH, Meade TW, Martin JC, Imeson JD, Cooper JA, Finch A: Factor VII-deficient substrate plasmas depleted of protein C raise the sensitivity of the factor VII bio-assay to activated factor VII: An international study. Thromb Haemost 71:38, 1994
11. Ruddock V, Meade TW: Factor VII activity and ischaemic heart disease: Fatal and non-fatal events. Q J Med 87:403, 1994
12. Heinrich J, Balleisen L, Schulte H, Assmann G, van de Loo J: Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men. Arterioscler Thromb 14:54, 1994
13. Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WRS, Haines AP, Stirling Y, Imeson JD, Thompson SG: Haemostatic function and ischaemic heart disease: Principal results of the Northwick Park Heart Study. Lancet 2:533, 1986
14. Constantino M, Merskey C, Kudzma DJ, Zucker MB: Increased activity of vitamin K-dependent clotting factors in human hyperlipoproteinaemia - Association with cholesterol and triglyceride levels. Thromb Haemost 38:465, 1977
15. Simpson HCR, Mann JI, Meade TW, Chakrabarti R, Stirling Y, Woolf L: Hypertriglyceridaemia and hypercoagulability. Lancet 1:786, 1983
16. Mitropoulos KA, Miller GJ, Reeves BEA, Wilkes HC, Cruickshank JK: Factor VII coagulant activity is strongly associated with the plasma concentration of large lipoprotein particles in middle-aged men. Atherosclerosis 76:203, 1989
17. Bruckert E, Carvalho de Sousa J, Giral P, Soria C, Chapman MJ, Caen J, de Gennes J-L: Interrelationship of plasma triglyceride and coagulant factor VII levels in normotriglyceridemic hypercholesterolemia. Atherosclerosis 75:129, 1989
18. Hoffman CJ, Lawson WE, Miller RH, Hultin MB: Correlation of vitamin K-dependent clotting factors with cholesterol and triglycerides in healthy young adults. Arterioscler Thromb 14:1737, 1994
19. Miller GJ, Cruickshank JK, Ellis LJ, Thompson RL, Wilkes HC, Stirling Y, Mitropoulos KA, Allison JV, Fox TE, Walker AO: Fat consumption and factor VII coagulant activity in middle-aged men. An association between a dietary and thrombogenic coronary risk factor. Atherosclerosis 78:19, 1989
20. Connelly JB, Roderick PJ, Cooper JA, Meade TW, Miller GJ: Positive association between self-reported fatty food consumption and factor VII coagulant activity, a risk factor for coronary heart disease, in 4246 middle-aged men. Thromb Haemost 70:250, 1993
21. Marckmann P, Sandstrom B, Jespersen J: Effects of total fat content and fatty acid composition in diet on factor VII coagulant activity and blood lipids. Atherosclerosis 80:227, 1990
22. Miller GJ, Stirling Y, Howarth DJ, Cooper JC, Green FR, Lane A, Humphries SE: Dietary fat intake and plasma factor VII antigen concentration. Thromb Haemost 73:893, 1995
23. Miller GJ, Walter SJ, Stirling Y, Thompson SG, Esnouf MP, Meade TW: Assay of factor VII activity by two techniques: Evidence for increased conversion of VII to α VIIa in hyperlipidaemia, with possible implications for ischaemic heart disease. Br J Haematol 59:249, 1985
24. Miller GJ, Martin JC, Mitropoulos KA, Reeves BEA, Thompson RL, Meade TW, Cooper JA, Cruickshank JK: Plasma factor VII is activated by postprandial triglyceridaemia, irrespective of dietary fat composition. Atherosclerosis 86:163, 1991
25. Silveira A, Karpe F, Blomback M, Steiner G, Walldius G, Hamsten A: Activation of coagulation factor VII during alimentary lipemia. Arterioscler Thromb 14:60, 1994
26. Bladbjerg EM, Marckmann P, Sandstrom B, Jespersen J: Non-fasting factor VII coagulant activity (FVII:c) increased by high-fat diet. Thromb Haemost 71:755, 1994
27. Salomaa V, Rasi V, Pekkanen J, Jauhiainen M, Vahtera E, Pietinen P, Korhonen H, Kuulasmaa K, Ehnholm C: The effects of saturated fat and n-6 polyunsaturated fat on postprandial lipemia and hemostatic activity. Atherosclerosis 103:1, 1993
28. Mitropoulos KA, Miller GJ, Watts GF, Durrington PN: Lipolysis of triglyceride-rich lipoproteins activates coagulant factor XII: A study in familial lipoprotein-lipase deficiency. Atherosclerosis 95:119, 1992
29. Mitropoulos KA, Esnouf MP: The autoactivation of factor XII in the presence of long-chain saturated fatty acids - a comparison with the potency of sulphatides and dextran sulphate. Thromb Haemost 66:446, 1991
30. Weiss R, Silverberg M, Kaplan AP: The effect of Cl inhibitor upon Hageman factor autoactivation. Blood 68:239, 1986
31. Mitropoulos KA, Martin JC, Stirling Y, Morrissey JH, Cooper JA: Activation of factors XII and VII induced in citrated plasma in the presence of contact surface. Thromb Res 78:67, 1995
32. Mitropoulos KA, Reeves BEA, O'Brien DP, Cooper JA, Martin JC: The relationship between factor VII coagulant activity and factor XII activation induced in plasma by endogenous or exogenously added contact surface. Blood Coag Fibrinol 4:223, 1993
33. Seligsohn U, Osterud B, Griffin JH, Rapaport SI: Evidence for the participation of both activated factor XII and activated factor IX in cold-promoted activation of factor VII. Thromb Res 13:1049, 1978
34. Holland B, Welch AA, Unwin ID, Buss DH, Paul AA, Southgate DAT: McCance and Widdowson's The Composition of Foods (ed 5). Cambridge, UK, Royal Society of Chemistry, 1991
35. Lechner K, Deutsch E: Eine einfache methode zur herstel-lung von menschlichem faktor-VII-mangelplasma. Thromb Diath Haemorrh 18:252, 1967
36. Boisclair MD, Lane DA, Philippou H, Esnouf MP, Sheikh S, Hunt B, Smith KJ: Mechanisms of thrombin generation during surgery and cardiopulmonary bypass. Blood 82:3350, 1993
37. Fujikawa K, Heimark RL, Kurachi K, Davie EW: Activation of bovine factor XII (Hageman factor) by plasma kallikrein. Biochemistry 19:1322, 1980
38. Shimada T, Kato H, Iwanaga S, Iwamori M, Nagai Y: Activation of factor XII and prekallikrein with cholesterol sulfate. Thromb Res 38:21, 1985
39. Bagdasarian A, Lahiri B, Colman RW: Origin of the high molecular activator of prekallikrein. J Biol Chem 248:7742, 1973
40. Silverberg M, Dunn JT, Garen L, Kaplan AP: Autoactivation of human Hageman factor. Demonstration utilizing a synthetic substrate. J Biol Chem 255:7281, 1980
41. Mandle R, Kaplan AP: Hageman factor substrates. Human plasma prekallikrein: Mechanism of activation by Hageman factor and participation in Hageman factor-dependent fibrinolysis. J Biol Chem 252:6097, 1977
42. Cochrane CG, Revak SD, Wuepper KD: Activation of Hageman factor in solid and fluid phases. A critical role of kallikrein. J Exp Med 138:1564, 1973
43. Tankersley DL, Finlayson JS: Kinetics of activation and autoactivation of human factor XII. Biochemistry 23:273, 1984
44. Ratnoff OD, Davie EW, Mallett DL: Studies on the action of Hageman factor: Evidence that activated Hageman factor in turn activates plasma thromboplastin antecedent. J Clin Invest 40:803, 1961
45. Thompson RE, Mandle R, Kaplan AP: Association of factor XI and high molecular weight kininogen in human plasma. J Clin Invest 60:1376, 1977
46. Schiffman S, Rapaport SI, Patch MJ: The identification and synthesis of activated plasma thromboplastin component (PTC). Blood 22:733, 1963
47. Wildgoose P, Kisiel W: Activation of human factor VII by factors IXa and Xa on human bladder carcinoma cells. Blood 73:1888, 1989
48. Tans G, Rosing J, Berrettini M, Lammle B, Griffin JH: Autoactivation of human plasma prekallikrein. J Biol Chem 262:11308, 1987
49. Naito K, Fujikawa K: Activation of human blood coagulation factor XI independent of factor XII. Factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces. J Biol Chem 266:7353, 1991
50. Gailani D, Broze GJ: Factor XII-independent activation of factor XI in plasma: Effects of sulfatides on tissue factor-induced coagulation. Blood 82:813, 1993
51. Von dem Borne PAK, Koppelman SJ, Bouma BN, Meijers JCM: Surface independent factor XI activation by thrombin in the presence of high molecular weight kininogen. Thromb Haemost 72:397, 1994
52. Osterud B, Bouma BN, Griffin JH: Human blood coagulation factor IX. Purification, properties, and mechanism of activation by activated factor XI. J Biol Chem 253:5946, 1978
53. Enfield DL, Thompson AR: Cleavage and activation of human factor IX by serine proteases. Blood 64:821, 1984
54. Laake K, Osterud B: Activation of purified factor VII by human plasmin, plasma kallikrein and activated components of the human intrinsic blood coagulation mechanism. Thromb Res 5:759, 1974
55. 2: Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase. J Clin Invest 80:341, 1987
56. Bauer KA, Kass BL, ten Cate H, Hawiger JJ, Rosenberg RD: Factor IX is activated in vivo by the tissue factor mechanism. Blood 76:731, 1990
57. Masys DR, Bajaj SP, Rapaport SI: Activation of human factor VII by activated factors IX and X. Blood 60:1143, 1982
58. Nuijens JH, Huijbregts CCM, Cohen M, Navis GO, de Vries A, Eerenberg AJM, Bakker JC, Hack CE: Detection of activation of the contact system of coagulation in vitro and in vivo: Quantitation of activated Hageman factor-Cl-inhibitor and kallikrein-Cl-inhibitor complexes by specific radioimmunoassays. Thromb Haemost 58:778, 1987